Tech Stocks Top S&P 500, Dow in 2001

January 2, 2002 (PLANSPONSOR.com) - Computer graphics chipmaker NVIDIA was the best performing stock in the S&P 500 in 2001, climbing 308% for the year according to Instinet Research and Analytics.

The company, which makes graphics chips for Microsoft’s new Xbox, was a newcomer to the index, having just three weeks ago replaced last year’s performance king, Enron , in the blue chip standard.

Microsoft , also in the S&P 500, fared best among the 30 stocks of the Dow Jones Industrial Average, climbing nearly 53% last year. Boeing’s 41% tumble earned it the dubious distinction of the poorest performer in the Dow.

For more stories like this, sign up for the PLANSPONSOR NEWSDash daily newsletter.

Turnaround

At the bottom of the S&P 500 list was credit-card company Providian Financial , which fell more than 93% during the year. Providian has been named as a potential target for a 401(k) participant lawsuit. Enron, the largest bankruptcy in American history, is currently under fire from participants, creditors and lawmakers. Had the energy trader remained in the S&P 500, it would have topped the bottom, falling more than 99% in 2001 from $83.13/share when 2001 began.

Other shining stars in the S&P 500 included Office Depot (up 160%), Best Buy and Autozone (each ending the year 152% higher) and J.C. Penney, which ended the year 147% higher.

In addition to Providian, the worst-performing stocks in the S&P 500 were Corning (down 83%), US Airways (84% lower), Applied Micro Circuits (down 85%) and Palm, which was down 86% for the year.

In 1999, Qualcomm’s 2,600% surge topped the S&P 500, but the stock now trades nearly 75% lower than its 1999 high.

Dow Beaters

International Business Machines (IBM) racked up a 42% gain during the year, good enough for second place in the Dow. Johnson & Johnson’s 13% gain earned it a ‘bronze’ in the Dow performance chart, barely edging out Home Depot, which rose 12% for the year.

It was a rough year for Hewlett-Packard and American Express (each down 35%) and Merck, which lost 37%.

«